CHARLES FOULDS to Cyclin-Dependent Kinase 6
This is a "connection" page, showing publications CHARLES FOULDS has written about Cyclin-Dependent Kinase 6.
Connection Strength
0.230
-
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer. Mol Cancer Ther. 2024 Oct 01; 23(10):1494-1510.
Score: 0.230
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.